UnitedHealth Group (NYSE:UNH) Issues Quarterly Earnings Results, Beats Estimates By $0.55 EPS

UnitedHealth Group (NYSE:UNH) announced its quarterly earnings results on Tuesday. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55, reports. The firm had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the company earned $2.59 earnings per share. UnitedHealth Group updated its FY 2026 guidance to 20.500- EPS.

Here are the key takeaways from UnitedHealth Group’s conference call:

• Third-quarter results improved materially, with revenue of $113 billion, adjusted EPS of $4.69 versus $2.92 a year ago, and a consolidated medical care ratio of 88.4% versus 89.9%.
• UnitedHealth raised its 2026 adjusted EPS outlook to at least $20.50 and said it views the result as a solid base for returning to its 13%-16% long-term growth target, while repurchasing $5 billion of stock through the third quarter.
• Medicare Advantage and Medicaid showed improving performance. Medicare margins are now expected near the top of the 2%-4% range, while Medicaid margins are projected to be moderately better than negative 1% for 2026, with further recovery targeted in 2027 and 2028.
• Medical costs remain elevated, particularly in commercial insurance, specialty pharmacy, acute care, and behavioral health. Commercial benefit trends are running above 11%, with No Surprises Act arbitration awards and clinician pricing pressure adding significant cost and delaying margin recovery.
• Management highlighted growing benefits from AI, modernization, and integrated value-based care, including reduced chart-review and appeal-processing times, fewer prior authorizations, and new Optum Insight AI products. However, additional technology and workflow investments will weigh on Optum Health’s fourth-quarter results as the company builds toward its 6%-8% margin target.

UnitedHealth Group Stock Up 0.0%

Shares of UNH opened at $378.59 on Wednesday. The company has a market capitalization of $339.82 billion, a P/E ratio of 24.36, a PEG ratio of 1.42 and a beta of 0.60. UnitedHealth Group has a one year low of $255.96 and a one year high of $461.62. The business’s 50 day simple moving average is $387.44 and its 200-day simple moving average is $382.57. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s payout ratio is presently 59.72%.

Analyst Ratings Changes

UNH has been the subject of a number of recent research reports. Mizuho increased their target price on UnitedHealth Group from $470.00 to $493.00 and gave the stock an “outperform” rating in a report on Monday, July 20th. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Royal Bank Of Canada upped their price target on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research report on Friday, July 17th. Evercore lifted their price objective on UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a report on Tuesday, July 7th. Finally, Argus boosted their target price on shares of UnitedHealth Group from $400.00 to $470.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $462.59.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, well above the approximately $4.14 analyst consensus, while revenue of $112.7 billion also exceeded estimates. Operating earnings rose 52% to $6.6 billion, supported by tighter medical-cost controls and improved execution. UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
• Positive Sentiment: Management raised its 2026 adjusted EPS outlook to at least $20.50, above the roughly $19.86 consensus estimate. The company also indicated that current analyst expectations for 2027 may be conservative, reinforcing the view that its turnaround is progressing. UnitedHealth Says Wall Street May Be Underestimating Its 2027 Earnings Potential
• Positive Sentiment: The medical care ratio improved to 88.4%, while artificial-intelligence tools reportedly reduced clinical-review times and administrative friction. Management also expects Medicaid margins to bottom in 2026 and improve thereafter. UnitedHealth Group Earnings Call Highlights Growth and AI
• Neutral Sentiment: Despite the earnings beat, revenue was essentially flat year over year and Optum Health revenue slipped, suggesting that the recovery is being driven more by margins and cost discipline than by broad-based top-line expansion.
• Negative Sentiment: Investors remain concerned about UnitedHealth’s Medicare strategy, including the impact of exiting or reducing exposure to less-profitable Medicare business. Those concerns cloud the otherwise strong quarter and explain why the stock reversed its early advance. UnitedHealth Group Drops 5.4% as Medicare Exit Clouds Q3 Beat

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.